Internal Server Error

Halo Pharma - About the company

Halo Pharma is an acquired company based in Hanover (United States), founded in 2006. It operates as a CDMO offering integrated drug development services. Halo Pharma has raised $25M in funding. The company has 875 active competitors, including 27 funded and 138 that have exited. Its top competitors include companies like Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals.

Company Details

Halo Pharmaceutical is a contract development and manufacturing organization which specializes in pediatric dosage forms. Services offered include pharmaceutical development, commercial manufacturing, analytical services for APIs and testing services. Pharmaceutical development services offered include project management, formulation development and analytical development. It has acquired manufacturing facilities from companies like Abbott and Teva to meet the commercial manufacturing needs of its clients by supplying solids, liquids, sterile ointment and packaging services. It also offers chemical and analytical services for pharmaceutical key intermediates and API – from development to small-scale commercial production. Testing services offered include chemical and microbiological testing of a complete range of dosage form. Recently, it entered into agreement with Exx pharma to Collaborate on the Development/Manufacturing of Products using Twin Screw Extrusion Technology.
Key Metrics
Founded Year
2006
Location
Hanover, United States
Stage
Acquired
Total Funding
$25M in 2 rounds
Latest Funding Round
Investors
Ranked
Employee Count
4 as on Jun 30, 2026
Exit Details
Acquired by Cambrex (Jul 23, 2018)

Halo Pharma's acquisition details

Halo Pharma got acquired by Cambrex on Jul 23, 2018 at an acquisition amount of $*****.
Click here to take a look at Halo Pharma's acquisition in detail
Sign up to download Halo Pharma's company profile

Halo Pharma's funding and investors

Halo Pharma has raised a total funding of $25M over 2 rounds. Its first funding round was on Jan 06, 2015. Halo Pharma has 2 institutional investors.

Here is the list of recent funding rounds of Halo Pharma:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Mar 10, 2025
8919672
Series B
6760569
9460390
5738913
7279758
Jan 06, 2015
5544184
PE
3585800
5851760
8300295
lockAccess funding benchmarks and valuations. Sign up today!

Halo Pharma's founders and board of directors

Founder? Claim Profile

Halo Pharma's employee count trend

Halo Pharma has 4 employees as of Jun 26. Here is Halo Pharma's employee count trend over the years:
Employee count trend for Halo Pharma
lockUncover Halo Pharma's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Halo Pharma's Competitors and alternates

Top competitors of Halo Pharma include Jubilant Life Sciences, Akums and Nivagen Pharmaceuticals. Here is the list of Top 10 competitors of Halo Pharma, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Jubilant Life Sciences
Jubilant Life Sciences
1978, Noida (India), Public
Company offering a suite of R&D and manufacturing services for small molecules and generics
-
59/100
2nd
Logo for Akums
Akums
2004, Delhi (India), Public
CDMO focusing on spectrum of dosage forms and therapeutic segments
$70M
58/100
3rd
Logo for Nivagen Pharmaceuticals
Nivagen Pharmaceuticals
2009, Sacramento (United States), Acquired
Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution
$31M
57/100
4th
Logo for Nectar Lifesciences
Nectar Lifesciences
1995, Chandigarh (India), Public
Manufacturer of cephalosporin APIs and generic formulations
$46.9M
55/100
5th
Logo for Recipharm
Recipharm
1995, Jordbro (Sweden), Acquired
Contract services for pharmaceutical development and manufacturing
-
54/100
6th
Logo for Supriya Lifescience
Supriya Lifescience
2008, Mumbai (India), Public
Manufacturer of active pharmaceutical ingredients and finished dosage formulations for healthcare
-
-
54/100
7th
Logo for Labiana
Labiana
1958, Corbera de Llobregat (Spain), Unfunded
Contract laboratory and contract manufacturing services for pharmaceutical and animal health industries
-
-
54/100
8th
Logo for Chugai Pharmaceutical
Chugai Pharmaceutical
1925, Tokyo (Japan), Acquired
Developer of innovative pharmaceutical products and services
-
54/100
9th
Logo for Jubilant Pharmova
Jubilant Pharmova
2020, Amroha (India), Public
CDMO focused on manufacturing of solid, semi solid, liquid, and injectible drug formulations
-
53/100
10th
Logo for Asahi Kasei
Asahi Kasei
1931, Chiyoda-ku (Japan), Public
CDMO focused on manufacturing of liquid, solid & injectable drug formulations
-
53/100
13th
Logo for Halo Pharma
Halo Pharma
2006, Hanover (United States), Acquired
CDMO offering integrated drug development services
$25M
51/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Halo Pharma's competitors? Click here to see the top ones

Halo Pharma's Investments and acquisitions

Halo Pharma has made no investments or acquisitions yet.

Reports related to Halo Pharma

Here is the latest report on Halo Pharma's geography:

News related to Halo Pharma

lockFilter this list
Media has covered Halo Pharma for 1 event in last 1 year, It was about company updates.
Cambrex Completes Halo AcquisitionContract PharmaSep 12, 2018Cambrex, Halo Pharma
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Halo Pharma

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford